# RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)

> **NCT02026960** · NA · TERMINATED · sponsor: **Duke University** · enrollment: 14 (actual)

## Conditions studied

- Metastatic Renal Cell Carcinoma
- Genitourinary Cancer (Bladder, Prostate or Testicular)

## Interventions

- **DEVICE:** RNA extraction and amplification from biopsy specimens

## Key facts

- **NCT ID:** NCT02026960
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-03
- **Primary completion:** 2016-03
- **Final completion:** 2017-09-07
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** The sponsor's clinical program for the agent used in this study was discontinued.
- **Last updated:** 2018-12-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02026960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02026960, "RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02026960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*